Cargando…

Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models

INTRODUCTION: There are Challenges in statistically modelling immune responses to longitudinal HIV viral load exposure as a function of covariates. We define Bayesian Markov Chain Monte Carlo mixed effects models to incorporate priors and examine the effect of different distributional assumptions. W...

Descripción completa

Detalles Bibliográficos
Autores principales: Sempa, Joseph B., Rossouw, Theresa M., Lesaffre, Emmanuel, Nieuwoudt, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853324/
https://www.ncbi.nlm.nih.gov/pubmed/31721805
http://dx.doi.org/10.1371/journal.pone.0224723
_version_ 1783470025348218880
author Sempa, Joseph B.
Rossouw, Theresa M.
Lesaffre, Emmanuel
Nieuwoudt, Martin
author_facet Sempa, Joseph B.
Rossouw, Theresa M.
Lesaffre, Emmanuel
Nieuwoudt, Martin
author_sort Sempa, Joseph B.
collection PubMed
description INTRODUCTION: There are Challenges in statistically modelling immune responses to longitudinal HIV viral load exposure as a function of covariates. We define Bayesian Markov Chain Monte Carlo mixed effects models to incorporate priors and examine the effect of different distributional assumptions. We prospectively fit these models to an as-yet-unpublished data from the Tshwane District Hospital HIV treatment clinic in South Africa, to determine if cumulative log viral load, an indicator of long-term viral exposure, is a valid predictor of immune response. METHODS: Models are defined, to express ‘slope’, i.e. mean annual increase in CD4 counts, and ‘asymptote’, i.e. the odds of having a CD4 count ≥500 cells/μL during antiretroviral treatment, as a function of covariates and random-effects. We compare the effect of using informative versus non-informative prior distributions on model parameters. Models with cubic splines or Skew-normal distributions are also compared using the conditional Deviance Information Criterion. RESULTS: The data of 750 patients are analyzed. Overall, models adjusting for cumulative log viral load provide a significantly better fit than those that do not. An increase in cumulative log viral load is associated with a decrease in CD4 count slope (19.6 cells/μL (95% credible interval: 28.26, 10.93)) and a reduction in the odds of achieving a CD4 counts ≥500 cells/μL (0.42 (95% CI: 0.236, 0.730)) during 5 years of therapy. Using informative priors improves the cumulative log viral load estimate, and a skew-normal distribution for the random-intercept and measurement error results is a better fit compared to using classical Gaussian distributions. DISCUSSION: We demonstrate in an unpublished South African cohort that cumulative log viral load is a strong and significant predictor of both CD4 count slope and asymptote. We argue that Bayesian methods should be used more frequently for such data, given their flexibility to incorporate prior information and non-Gaussian distributions.
format Online
Article
Text
id pubmed-6853324
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-68533242019-11-22 Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models Sempa, Joseph B. Rossouw, Theresa M. Lesaffre, Emmanuel Nieuwoudt, Martin PLoS One Research Article INTRODUCTION: There are Challenges in statistically modelling immune responses to longitudinal HIV viral load exposure as a function of covariates. We define Bayesian Markov Chain Monte Carlo mixed effects models to incorporate priors and examine the effect of different distributional assumptions. We prospectively fit these models to an as-yet-unpublished data from the Tshwane District Hospital HIV treatment clinic in South Africa, to determine if cumulative log viral load, an indicator of long-term viral exposure, is a valid predictor of immune response. METHODS: Models are defined, to express ‘slope’, i.e. mean annual increase in CD4 counts, and ‘asymptote’, i.e. the odds of having a CD4 count ≥500 cells/μL during antiretroviral treatment, as a function of covariates and random-effects. We compare the effect of using informative versus non-informative prior distributions on model parameters. Models with cubic splines or Skew-normal distributions are also compared using the conditional Deviance Information Criterion. RESULTS: The data of 750 patients are analyzed. Overall, models adjusting for cumulative log viral load provide a significantly better fit than those that do not. An increase in cumulative log viral load is associated with a decrease in CD4 count slope (19.6 cells/μL (95% credible interval: 28.26, 10.93)) and a reduction in the odds of achieving a CD4 counts ≥500 cells/μL (0.42 (95% CI: 0.236, 0.730)) during 5 years of therapy. Using informative priors improves the cumulative log viral load estimate, and a skew-normal distribution for the random-intercept and measurement error results is a better fit compared to using classical Gaussian distributions. DISCUSSION: We demonstrate in an unpublished South African cohort that cumulative log viral load is a strong and significant predictor of both CD4 count slope and asymptote. We argue that Bayesian methods should be used more frequently for such data, given their flexibility to incorporate prior information and non-Gaussian distributions. Public Library of Science 2019-11-13 /pmc/articles/PMC6853324/ /pubmed/31721805 http://dx.doi.org/10.1371/journal.pone.0224723 Text en © 2019 Sempa et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Sempa, Joseph B.
Rossouw, Theresa M.
Lesaffre, Emmanuel
Nieuwoudt, Martin
Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models
title Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models
title_full Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models
title_fullStr Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models
title_full_unstemmed Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models
title_short Cumulative viral load as a predictor of CD4+ T-cell response to antiretroviral therapy using Bayesian statistical models
title_sort cumulative viral load as a predictor of cd4+ t-cell response to antiretroviral therapy using bayesian statistical models
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6853324/
https://www.ncbi.nlm.nih.gov/pubmed/31721805
http://dx.doi.org/10.1371/journal.pone.0224723
work_keys_str_mv AT sempajosephb cumulativeviralloadasapredictorofcd4tcellresponsetoantiretroviraltherapyusingbayesianstatisticalmodels
AT rossouwtheresam cumulativeviralloadasapredictorofcd4tcellresponsetoantiretroviraltherapyusingbayesianstatisticalmodels
AT lesaffreemmanuel cumulativeviralloadasapredictorofcd4tcellresponsetoantiretroviraltherapyusingbayesianstatisticalmodels
AT nieuwoudtmartin cumulativeviralloadasapredictorofcd4tcellresponsetoantiretroviraltherapyusingbayesianstatisticalmodels